Literature DB >> 16626293

Convergence of the SUMO and MAPK pathways on the ETS-domain transcription factor Elk-1.

Shen-Hsi Yang1, Andrew D Sharrocks.   

Abstract

The ETS-domain transcription factor Elk-1 is regulated by phosphorylation in response to activation of the MAPK (mitogen-activated protein kinase) pathways. This phosphorylation triggers a series of molecular events that convert Elk-1 from a transcriptionally silent state into a highly active state and then back to a basal level. At the same time, activation of the ERK (extracellular-signal-regulated kinase) MAPK pathway leads to loss of modification of Elk-1 by SUMO (small ubiquitin-related modifier). As SUMO imparts repressive properties on Elk-1, ERK-mediated SUMO loss leads to de-repression at the same time as the ERK pathway promotes activation of Elk-1. Thus a two-step mechanism is employed to convert Elk-1 into its fully activated state. Here, the molecular events underlying these changes in Elk-1 status, and the role of PIASxalpha [protein inhibitor of activated STAT (signal transducer and activator of transcription) xalpha] as a co-activator that facilitates this process, are discussed.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16626293     DOI: 10.1042/bss0730121

Source DB:  PubMed          Journal:  Biochem Soc Symp        ISSN: 0067-8694


  20 in total

1.  SUMO-, MAPK-, and resistance protein-signaling converge at transcription complexes that regulate plant innate immunity.

Authors:  Harrold A van den Burg; Frank L W Takken
Journal:  Plant Signal Behav       Date:  2010-12-01

Review 2.  Location-dependent signaling of the group 1 metabotropic glutamate receptor mGlu5.

Authors:  Yuh-Jiin I Jong; Ismail Sergin; Carolyn A Purgert; Karen L O'Malley
Journal:  Mol Pharmacol       Date:  2014-10-17       Impact factor: 4.436

3.  Chlorpromazine activates p21Waf1/Cip1 gene transcription via early growth response-1 (Egr-1) in C6 glioma cells.

Authors:  Soon Young Shin; Chang Gun Kim; Se Hyun Kim; Yong Sik Kim; Yoongho Lim; Young Han Lee
Journal:  Exp Mol Med       Date:  2010-05-31       Impact factor: 8.718

4.  AC3-33, a novel secretory protein, inhibits Elk1 transcriptional activity via ERK pathway.

Authors:  Dongxia Hao; Peng Gao; Peng Liu; Jie Zhao; Yang Wang; Wenping Yang; Yang Lu; Taiping Shi; Xiujun Zhang
Journal:  Mol Biol Rep       Date:  2010-08-03       Impact factor: 2.316

5.  The ETS family transcription factor ELK-1 regulates induction of the cell cycle-regulatory gene p21(Waf1/Cip1) and the BAX gene in sodium arsenite-exposed human keratinocyte HaCaT cells.

Authors:  Soon Young Shin; Chang Gun Kim; Yoongho Lim; Young Han Lee
Journal:  J Biol Chem       Date:  2011-06-03       Impact factor: 5.157

6.  The Elk-1 and serum response factor binding sites in the major immediate-early promoter of human cytomegalovirus are required for efficient viral replication in quiescent cells and compensate for inactivation of the NF-kappaB sites in proliferating cells.

Authors:  Patrizia Caposio; Anna Luganini; Matteo Bronzini; Santo Landolfo; Giorgio Gribaudo
Journal:  J Virol       Date:  2010-02-10       Impact factor: 5.103

Review 7.  Back to your heart: ubiquitin proteasome system-regulated signal transduction.

Authors:  Andrea L Portbury; Sarah M Ronnebaum; Makhosazane Zungu; Cam Patterson; Monte S Willis
Journal:  J Mol Cell Cardiol       Date:  2011-11-06       Impact factor: 5.000

8.  Regulation of P2X(7) gene transcription.

Authors:  Lingyin Zhou; Liping Luo; Xiaoping Qi; Xin Li; George I Gorodeski
Journal:  Purinergic Signal       Date:  2009-07-16       Impact factor: 3.765

9.  Protein profiles associated with context fear conditioning and their modulation by memantine.

Authors:  Md Mahiuddin Ahmed; A Ranjitha Dhanasekaran; Aaron Block; Suhong Tong; Alberto C S Costa; Katheleen J Gardiner
Journal:  Mol Cell Proteomics       Date:  2014-01-27       Impact factor: 5.911

10.  Synapsins Are Downstream Players of the BDNF-Mediated Axonal Growth.

Authors:  Antonella Marte; Mirko Messa; Fabio Benfenati; Franco Onofri
Journal:  Mol Neurobiol       Date:  2016-01-07       Impact factor: 5.590

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.